olivlawolivlaw

olivLaw · US equity research

Superior Group of Companies, Inc. SGC

Apparel & Other Finishd Prods of Fabrics & Similar Matl · SIC 2300 · Vertical: Apparel & Other Finishd Prods of Fabrics & Similar Matl (SIC 2300)

14.08USD+7.98% · 1 dayClose 04 Nov 2026

Superior Group of Companies (SGC) is a US group with three segments: branded promotional products and uniforms, healthcare apparel and nearshore contact centers. The company is under margin pressure, and in 2026 its sales guidance and tariff rules remain the points to watch.

At the close of 04 Nov 2026, Superior Group of Companies, Inc. (SGC) stock was 14.08 USD (+7.98% on the day), with market capitalisation 224.5 m USD, P/E 25.6 on diluted EPS of 0.55 USD over the last 12 months, dividend yield 3.98%, beta 0.92, 52-week range 8.48–14.13 USD. Latest reported quarter (Q2 2026): revenue of 147.8 m USD (+2.6% YoY), net income of 1.2 m USD (−21.3% YoY), diluted EPS 0.08 USD.

Data as of · AI analysis dated · Source: SEC filings and closing prices, computed by olivLaw.

Market cap
224.5 m USD
shares as of 30 Jul 2026
P/E (TTM)
25.6
Diluted EPS TTM 0.55 · TTM to 30 Jun 2026
E/P (TTM)
3.91%
TTM to 30 Jun 2026
Dividend yield
3.98%
DPS 12m 0.56
Beta (2y)
0.92
Volatility (1y) 45%
52-week range
8.4814.13

Price history

Loading chart…

Technical reading

RSI (14)
65.0
strong (55–70)
Bollinger (20, 2)
12.22 – 13.82
above the upper band · %B 1.16 · band width 12.3%
SMA 50 / 200
12.74 / 11.90
uptrend (price > SMA50 > SMA200)
MACD (12, 26, 9)
0.09 / 0.02
MACD above signal

Indicators describe past prices; on their own they do not predict direction. On our history the RSI ≤ 40 filter added no return (see the signals methodology).

Performance

CompanyS&P 500vs S&P 500Vertical median
1 month+8.3%−1.1%+9.4 pp—
3 months+1.8%−0.5%+2.3 pp—
6 months+17.7%+4.4%+13.3 pp—
Year to date+45.5%+12.3%+33.1 pp—
1 year+53.5%+13.5%+40.0 pp+6.7%
3 years+74.3%+76.4%−2.2 pp+2.9%
5 years−44.0%+63.7%−107.7 pp—
Max drawdown (1y)
−16.2%
12 Jun 2026 → 22 Jun 2026
Max drawdown (5y)
−71.7%
16 Nov 2021 → 05 Apr 2023
Compound annual growth (5y)
−11.0%
S&P 500 +10.4%

Price returns, dividends excluded.

Quarterly results

Latest quarter: Q2 2026 · 30 Jun 2026

Revenue
147.8 m USD
+2.6% YoY
Net income
1.2 m USD
−21.3% YoY
Diluted EPS
0.08
−20.0% YoY
net / operating
0.8% / unavailable

Quarterly margins

Quarterly statements · USD

Fiscal yearQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Revenue149.7 m145.4 m137.1 m144.0 m138.5 m146.6 m140.9 m147.8 m
Cost of revenue89.1 m91.4 m86.7 m88.7 m85.4 m92.6 m88.5 m91.7 m
Gross profit60.5 m54.0 m50.4 m55.3 m53.1 m54.0 m52.3 m—
SG&A52.4 m50.0 m50.1 m52.2 m48.5 m48.6 m50.4 m51.3 m
Depreciation & amortisation3.3 m3.3 m3.2 m3.0 m3.0 m3.2 m2.9 m2.9 m ≈
Interest expense1.6 m1.5 m1.2 m1.3 m1.4 m1.3 m912.0 k981.0 k
Pre-tax income6.6 m2.5 m-906.0 k1.8 m3.2 m4.1 m1.1 m1.2 m
Income tax1.2 m390.0 k-148.0 k285.0 k443.0 k666.0 k220.0 k-10.0 k
Net income5.4 m2.1 m-758.0 k1.6 m2.7 m3.5 m834.0 k1.2 m
Diluted EPS0.330.13 ≈-0.050.100.180.23 ≈0.060.08
Operating cash flow8.2 m ≈8.9 m-2.0 m4.9 m ≈-1.7 m ≈18.4 m9.4 m8.4 m ≈
Capex937.0 k1.5 m1.1 m1.6 m ≈691.0 k ≈540.0 k568.0 k1.3 m ≈
Dividends paid2.3 m ≈2.3 m2.3 m2.2 m ≈2.2 m ≈2.2 m2.2 m2.2 m ≈
Share repurchases6.3 m ≈1.1 m3.8 m4.1 m ≈2.0 k ≈2.2 m678.0 k85.0 k ≈

≈ derived quarter (cumulative difference / share-days average)

E/P over time

E/P = trailing-12-month diluted EPS / price at quarter end. E/P is the inverse of P/E and stays defined when earnings are negative.

Today's P/E sits at the 88 percentile of its own 34-quarter history (min 8.0, median 18.3, max 29.9; quarters with earnings only).

Fiscal years

Fiscal year20182019202020212022202320242025
Revenue346.4 m376.7 m526.7 m537.0 m578.8 m543.3 m565.7 m566.2 m
Revenue YoY+29.8%+8.8%+39.8%+2.0%+7.8%−6.1%+4.1%+0.1%
Net income17.0 m12.1 m41.0 m29.4 m-32.0 m8.8 m12.0 m7.0 m
Net income YoY+13.0%−28.9%+240.0%−28.2%−208.6%unavailable+36.8%−41.7%
Diluted EPS1.100.792.651.83-2.030.540.730.46
Diluted EPS YoY+11.1%−28.2%+235.4%−30.9%−210.9%unavailable+35.2%−37.0%
net %4.9%3.2%7.8%5.5%-5.5%1.6%2.1%1.2%
Free cash flow15.0 m10.3 m29.5 m-616.0 k-13.6 m74.0 m29.0 m15.8 m

Reported results vs expectations

Loading…

Balance sheet & financial health

Fiscal year 2025 · 31 Dec 2025

Cash
23.7 m USD
Financial debt
93.7 m USD
Net debt
70.0 m USD
Equity
192.8 m USD
Total assets
421.8 m USD
Debt / equity
0.49x
Current ratio
2.66x
ROE
3.6%
ROA
1.7%
FCF margin
2.8%

Financial statements (source on every figure)

Revenue and net income (USD)

Margins

Income statement · USD

Revenue
2023
543.3 m
2024
565.7 m
2025
566.2 m

SEC (XBRL)· 03 Mar 2026verified

Cost of revenue
2023
339.8 m
2024
345.1 m
2025
353.3 m

SEC (XBRL)· 03 Mar 2026verified

Gross profit
2023
203.5 m
2024
220.6 m
2025
212.9 m

SEC (XBRL)· 03 Mar 2026verified

SG&A
2023
184.1 m
2024
199.9 m
2025
199.5 m

SEC (XBRL)· 03 Mar 2026verified

Depreciation & amortisation
2023
14.0 m
2024
13.2 m
2025
12.4 m

SEC (XBRL)· 03 Mar 2026verified

Interest expense
2023
9.7 m
2024
6.4 m
2025
5.1 m

SEC (XBRL)· 03 Mar 2026verified

Pre-tax income
2023
9.8 m
2024
14.3 m
2025
8.2 m

SEC (XBRL)· 03 Mar 2026verified

Income tax
2023
997.0 k
2024
2.3 m
2025
1.2 m

SEC (XBRL)· 03 Mar 2026verified

Net income
2023
8.8 m
2024
12.0 m
2025
7.0 m

SEC (XBRL)· 03 Mar 2026verified

Diluted EPS
2023
0.54
2024
0.73
2025
0.46

SEC (XBRL)· 03 Mar 2026verified

Weighted average diluted shares
2023
16.2 m
2024
16.5 m
2025
15.3 m

SEC (XBRL)· 03 Mar 2026verified

Dividend per share
2023
0.56
2024
0.56
2025
0.56

SEC (XBRL)· 03 Mar 2026verified

Balance sheet · USD

Cash
2023
19.9 m
2024
18.8 m
2025
23.7 m

SEC (XBRL)· 03 Mar 2026verified

Receivables
2023
103.5 m
2024
95.1 m
2025
104.3 m

SEC (XBRL)· 03 Mar 2026verified

Inventories
2023
98.1 m
2024
96.7 m
2025
97.5 m

SEC (XBRL)· 03 Mar 2026verified

Current assets
2023
279.4 m
2024
273.1 m
2025
287.7 m

SEC (XBRL)· 03 Mar 2026verified

Property, plant & equipment, net
2023
46.9 m
2024
41.9 m
2025
37.4 m

SEC (XBRL)· 03 Mar 2026verified

Goodwill
2023
0
2024
2.3 m
2025
2.6 m

SEC (XBRL)· 03 Mar 2026verified

Intangibles (excl. goodwill)
2023
51.2 m
2024
51.1 m
2025
47.3 m

SEC (XBRL)· 03 Mar 2026verified

Total assets
2023
422.5 m
2024
415.1 m
2025
421.8 m

SEC (XBRL)· 03 Mar 2026verified

Accounts payable
2023
50.5 m
2024
50.9 m
2025
48.3 m

SEC (XBRL)· 03 Mar 2026verified

Short-term debt
2023
4.7 m
2024
5.6 m
2025
6.6 m

SEC (XBRL)· 03 Mar 2026verified

Long-term debt
2023
88.8 m
2024
80.4 m
2025
87.1 m

SEC (XBRL)· 03 Mar 2026verified

Current liabilities
2023
100.6 m
2024
101.7 m
2025
107.9 m

SEC (XBRL)· 03 Mar 2026verified

Total liabilities
2023
224.8 m
2024
216.3 m
2025
229.0 m

SEC (XBRL)· 03 Mar 2026verified

Equity
2023
197.6 m †
2024
198.9 m †
2025
192.8 m †

SEC (XBRL)· 03 Mar 2026verified

Cash flow · USD

Operating cash flow
2023
78.9 m
2024
33.4 m
2025
19.7 m

SEC (XBRL)· 03 Mar 2026verified

Capex
2023
5.0 m
2024
4.4 m
2025
3.9 m

SEC (XBRL)· 03 Mar 2026verified

Free cash flow
2023
74.0 m ≈
2024
29.0 m ≈
2025
15.8 m ≈

SEC (XBRL)· 03 Mar 2026derived

Investing cash flow
2023
-5.5 m
2024
-8.4 m
2025
-3.9 m

SEC (XBRL)· 03 Mar 2026verified

Financing cash flow
2023
-71.6 m
2024
-24.5 m
2025
-11.8 m

SEC (XBRL)· 03 Mar 2026verified

Dividends paid
2023
9.2 m
2024
9.3 m
2025
8.9 m

SEC (XBRL)· 03 Mar 2026verified

Share repurchases
2023
0
2024
7.4 m
2025
10.1 m

SEC (XBRL)· 03 Mar 2026verified

Computed indicators

Growth

Revenue growth (YoY)
0.1%
computed by olivLawFY 2025
Revenue CAGR 3Y
-0.7%
computed by olivLawFY 2022 → FY 2025
Revenue CAGR 5Y
1.5%
computed by olivLawFY 2020 → FY 2025
EBIT growth (YoY)
unavailable
input data missing
Net income growth (YoY)
-41.7%
computed by olivLawFY 2025
Net income CAGR 3Y
unavailable
the base of the ratio is not positive
Net income CAGR 5Y
-29.8%
computed by olivLawFY 2020 → FY 2025
EPS growth (YoY)
-37.0%
computed by olivLawFY 2025
EPS CAGR 3Y
unavailable
the base of the ratio is not positive
EPS CAGR 5Y
-29.5%
computed by olivLawFY 2020 → FY 2025
FCF growth (YoY)
-45.6%
computed by olivLawFY 2025

Profitability

Gross margin
37.4%
computed by olivLawTTM to 30 Jun 2026
EBITDA margin
unavailable
input data missing
EBIT margin
unavailable
input data missing
Net margin
1.4%
computed by olivLawTTM to 30 Jun 2026
FCF margin
5.5%
computed by olivLawTTM to 30 Jun 2026

Returns

ROE
4.3%
computed by olivLawTTM to 30 Jun 2026 · balance sheet at 30 Jun 2026
ROA
2.0%
computed by olivLawTTM to 30 Jun 2026 · balance sheet at 30 Jun 2026
ROIC
unavailable
input data missing
ROCE
unavailable
input data missing
Payout ratio (EPS)
101.7%
computed by olivLawTTM to 30 Jun 2026
Payout ratio (FCF)
27.9%
computed by olivLawTTM to 30 Jun 2026

Balance sheet

Net debt
59.2 m USD
computed by olivLawbalance sheet at 30 Jun 2026
Net debt / EBITDA
unavailable
input data missing
Debt / equity
0.4x
computed by olivLawbalance sheet at 30 Jun 2026
Interest coverage
unavailable
input data missing

Liquidity

Current ratio
2.6x
computed by olivLawbalance sheet at 30 Jun 2026
Quick ratio
1.8x
computed by olivLawbalance sheet at 30 Jun 2026
Cash ratio
0.2x
computed by olivLawbalance sheet at 30 Jun 2026

Cash

Operating cash flow
34.5 m USD
computed by olivLawTTM to 30 Jun 2026
Capital expenditure
3.1 m USD
computed by olivLawTTM to 30 Jun 2026
Free cash flow
31.4 m USD
computed by olivLawTTM to 30 Jun 2026
FCF conversion
379.9%
computed by olivLawTTM to 30 Jun 2026
Cash conversion
unavailable
input data missing

Efficiency

Days sales outstanding
60 days
computed by olivLawTTM to 30 Jun 2026 · balance sheet at 30 Jun 2026
Days inventory outstanding
100 days
computed by olivLawTTM to 30 Jun 2026 · balance sheet at 30 Jun 2026
Days payables outstanding
54 days
computed by olivLawTTM to 30 Jun 2026 · balance sheet at 30 Jun 2026
Cash conversion cycle
106 days
computed by olivLawTTM to 30 Jun 2026 · balance sheet at 30 Jun 2026

Market and valuation

Market capitalisation
224.5 m USD
computed by olivLawbalance sheet at 30 Jun 2026
Enterprise value
283.7 m USD
computed by olivLawbalance sheet at 30 Jun 2026
Market cap / net income TTM
27.2x
computed by olivLawTTM to 30 Jun 2026
P/E (TTM)
25.6x
computed by olivLawTTM to 30 Jun 2026
Earnings yield
3.9%
computed by olivLawTTM to 30 Jun 2026
P/B
1.2x
computed by olivLawbalance sheet at 30 Jun 2026
P/S
0.4x
computed by olivLawTTM to 30 Jun 2026 · balance sheet at 30 Jun 2026
EV/EBITDA
unavailable
input data missing
EV/EBIT
unavailable
input data missing
EV/Sales
0.5x
computed by olivLawTTM to 30 Jun 2026 · balance sheet at 30 Jun 2026
P/FCF
7.2x
computed by olivLawTTM to 30 Jun 2026 · balance sheet at 30 Jun 2026
FCF yield
14.0%
computed by olivLawTTM to 30 Jun 2026 · balance sheet at 30 Jun 2026
Dividend yield
4.0%
computed by olivLawTTM to 30 Jun 2026
Shareholder yield (distributions)
5.2%
computed by olivLawTTM to 30 Jun 2026 · balance sheet at 30 Jun 2026

1 indicators that do not apply to the sector.

Valuation

olivLaw classification

Insufficient data
What is missing
  • score weight coverage: 54.2% of at least 60%

A scoring methodology on indicators and valuation, not investment advice.

Closing price

14.08 USD

04 Nov 2026Source: olivLaw, closing series

Market cap: 224.5 m USD

Key indicators

Market capitalisation
224.5 m USD
computed by olivLawbalance sheet at 30 Jun 2026
P/E (TTM)
25.6x
computed by olivLawTTM to 30 Jun 2026
P/B
1.2x
computed by olivLawbalance sheet at 30 Jun 2026
EV/EBITDA
unavailable
input data missing
ROE
4.3%
computed by olivLawTTM to 30 Jun 2026 · balance sheet at 30 Jun 2026
Net margin
1.4%
computed by olivLawTTM to 30 Jun 2026
Revenue growth (YoY)
0.1%
computed by olivLawFY 2025
Dividend yield
4.0%
computed by olivLawTTM to 30 Jun 2026

Coverage and freshness

33/37 reporting lines present
Latest full fiscal year: 2025
Latest reported period: 30 Jun 2026
Latest balance sheet date: 30 Jun 2026
Share count (cover of the latest filing), as of: 30 Jul 2026
Source: SEC (XBRL)published 04 Aug 2026
verified 2640derived 199

Score by group

54% · Insufficient data

Estimated value range

Low
7.36
USD per share
Mid
8.44
USD per share
High
9.90
USD per share
Price: 14.08 USD
The price is above the range
Potential to the central value: -40.0% (value / price − 1)
Margin of safety: -66.8% (1 − price / value)
Agreement between methods: medium · 3 methods used · 3 independent bases

The combined range = the median of the valid methods' low, central and high values; it is not a probability interval and does not cover every result. Envelope of all methods: 5.92 – 45.50 USD.

Valuation assumptions are editorial choices, not measured; beta is not measured.

Method ranges (USD per share)

— — Mid · ▏ Price

Valuation methods

  • DCF (discounted cash flow)26.04 – 45.50 (Mid 33.22)
    WACC 8.2% · starting FCFF 35.3 m USD · terminal value share of EV 76%
    The WACC × g sensitivity gives the method's bounds; these are not probabilities.
    Reverse DCF: starting growth implied by the price (fading linearly to terminal growth, everything else fixed): -28.4%
  • Peers: EV/EBITDAunavailable · input data missing
  • Peers: P/E5.92 – 9.13 (Mid 8.43)
    9 companies used · median multiple 15.3x · quartiles 10.8x – 16.6x
    AS, BRIA, COLM, CRI, GIII, GIL, JRSH, LEVI, LULU
  • Dividend discount (DDM)7.36 – 9.90 (Mid 8.44)
Multiple comparisons use the SIC vertical: Apparel & Other Finishd Prods of Fabrics & Similar Matl (SIC 2300)

Classification (SIC) comparables group by industry code, not by economic activity; the direct group is an editorial selection by activity. Members' multiples are on their own trailing twelve months, at their own latest close.

Assumptions (illustrative, editorial)

Risk-free rate
4.3%
Equity risk premium
5.0%
Beta (default)
1.00
Cost of equity
9.3%
Terminal growth
2.5%

Factor scorecard

Insufficient data

Minimum-evidence gate: score weight coverage: 54.2% of at least 60%

FactorValueScoreWeight used
ROIC · Qualityunavailableunavailable—
Net margin · Quality1.4%25 (vs peers)12%
FCF conversion · Quality379.9%100 (on a fixed band)12%
Revenue CAGR 3Y · Growth-0.7%0 (on a fixed band)15%
EPS CAGR 3Y · Growthunavailableunavailable—
Net debt / EBITDA · Balance sheetunavailableunavailable—
Interest coverage · Balance sheetunavailableunavailable—
Current ratio · Balance sheet2.6x100 (on a fixed band)8%
P/E (TTM) · Valuation25.6x27 (vs peers)19%
EV/EBITDA · Valuationunavailableunavailable—
FCF yield · Valuation14.0%100 (on a fixed band)15%
Shareholder yield (distributions) · Returns5.2%75 (on a fixed band)12%
Payout ratio (FCF) · Returns27.9%100 (on a fixed band)8%

Factors without a value were dropped; the remaining weights were renormalised.

Score groups

  • Balance sheet· partial100/100 · 1/3 factors with a value
  • Growth· partial0/100 · 1/2 factors with a value
  • Quality63/100 · 2/3 factors with a value
  • Returns85/100 · 2/2 factors with a value
  • Valuation60/100 · 2/3 factors with a value

A «partial» group is computed from under half of its weight or from one factor: it is not a full assessment of the group.

Memo

SUPERIOR GROUP OF COMPANIES, INC. (SGC). Latest full fiscal year: 2025; data up to 2026-06-30.

Figures computed from the financial statements: revenue 566.2 m USD in 2025; YoY growth 0.1%; net margin 1.4%; ROE 4.3%.

The estimated value range is 7.36–9.90 USD per share (median of 3 methods, agreement: medium); assumptions are illustrative. Against the central value of 8.44 USD, the price of 14.08 USD leaves a potential of -40.0% (value / price − 1) and a margin of safety of -66.8% (1 − price / value). The range is the median of the methods' low, central and high values, not a probability interval.

Insufficient data for a verdict (score weight coverage: 54.2% of at least 60%).

Text generated deterministically from the figures shown; no language model. Not investment advice.

What supports the thesis

  • FCF conversion: 379.9%
  • Current ratio: 2.6x
  • FCF yield: 14.0%
  • Shareholder yield (distributions): 5.2%
  • Payout ratio (FCF): 27.9%

What contradicts it

  • Net margin: 1.4%
  • Revenue CAGR 3Y: -0.7%
  • P/E (TTM): 25.6x
  • The price is above the estimated value range

Not assessed (insufficient data or a ratio without meaning): ROIC, EPS CAGR 3Y, Net debt / EBITDA, Interest coverage, EV/EBITDA.

Versus the vertical median

Apparel & Other Finishd Prods of Fabrics & Similar Matl (SIC 2300) · same industry (4-digit SIC) · compared with 16 companies

Multiples and returns vs the median

P/E
25.6x
vertical median 15.9x
above median (+60.9%)
EV/EBITDA
—
vertical median 4.3x
P/S
0.4x
vertical median 0.6x
below median (−38.0%)
P/B
1.2x
vertical median 1.8x
below median (−36.8%)
ROE
4.3%
vertical median 11.4%
below median (−62.4%)
Net margin
1.4%
vertical median 5.6%
below median (−74.3%)
EBIT margin
—
vertical median 7.5%
Revenue YoY
0.1%
vertical median 2.6%
below median (−96.6%)
Net debt/EBITDA
—
vertical median -0.2x
Dividend yield
4.0%
vertical median 2.1%
above median (+92.7%)

Price rebased to 100 (monthly, 5 years)

Companies in the vertical

Market capP/EROENet marginRevenue YoY1A / 3A
ASAmer Sports, Inc.17.9 bn42.27.9%6.5%+26.7%−14% / unavailable
LULUlululemon athletica inc.11.8 bn9.230.9%12.8%+4.9%−39% / −75%
GILGildan Activewear Inc.8.0 bn16.615.9%11.0%+10.7%−22% / +19%
COLMColumbia Sportswear Company3.6 bn18.412.7%6.0%+0.9%+32% / −9%
GIIIG III Apparel Group Ltd1.4 bn10.87.7%4.8%−7.0%+14% / +15%
CRICarter’s, Inc.1.2 bn5.522.9%7.4%unavailable+5% / −51%
LEVILevi Strauss & Co894.9 m15.925.8%8.8%+4.1%+8% / +54%
SGCSuperior Group Of Companies, Inc.224.5 m25.64.3%1.4%+0.1%+54% / +74%
JRSHJerash Holdings (US), Inc.73.8 m15.37.6%2.8%+14.0%+87% / +103%
PASWPing An Biomedical Co., Ltd.60.1 m—-28.4%-37.6%unavailable+541% / unavailable
BRIABrilliA Inc34.5 m11.521.5%4.4%+15.1%−23% / unavailable
NCINeo-Concept International Group Holdings Limited12.8 m63.10.6%0.2%−41.9%−93% / unavailable
LANVLanvin Group Holdings Limited——-200.4%-50.3%−22.9%−60% / −79%
FIGSFIGS, Inc.067.014.8%8.7%+13.6%+124% / +202%
ZGNErmenegildo Zegna N.V.——10.1%5.1%−1.5%+39% / +30%
GOOSCanada Goose Holdings Inc.——19.8%7.0%+1.1%−36% / −20%
UAUnder Armour, Inc.——-29.8%-10.0%−3.8%+26% / −27%

1- and 3-year price returns: for SGC from daily closes (the same as the performance table), for the other companies from month-end closes.

olivLaw engine forecast

The world engine ran after the company's latest material disclosure. Probabilities are of TOUCHING a level within the horizon (not closing there) and sit next to the random walk (p_rw), the no-information benchmark.

The engine has no published run for this company yet.

Valuation scenarios (editable assumptions)

Illustrative scenarios

Illustrative: not forecasts and without probabilities. Each case is one coherent set of assumptions, computed on today's figures.

Bear
Allowed range: -50 … 50%
Allowed range: -100 … 100%
Allowed range: 0 … 100
Allowed range: -10 … 20%
Allowed range: 0 … 100%
Base
Allowed range: -50 … 50%
Allowed range: -100 … 100%
Allowed range: 0 … 100
Allowed range: -10 … 20%
Allowed range: 0 … 100%
Bull
Allowed range: -50 … 50%
Allowed range: -100 … 100%
Allowed range: 0 … 100
Allowed range: -10 … 20%
Allowed range: 0 … 100%
Nothing is saved.

Estimated price (USD)

Estimated priceBearBaseBull
1 years
7.42
Total return -45% · Per year -45%
13.16
Total return -3% · Per year -3%
19.86
Total return 45% · Per year 45%
3 years
6.47
Total return -46% · Per year -19%
12.96
Total return 3% · Per year 1%
21.60
Total return 67% · Per year 19%
5 years
5.63
Total return -48% · Per year -12%
12.77
Total return 9% · Per year 2%
23.48
Total return 91% · Per year 14%
What moves the 3-year price the most
  • Exit P/E± 3.24
  • Net margin± 2.27
  • Annual revenue growth± 1.96
  • Annual dilution± 0.19

AI analysis

AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.

In brief

Superior Group of Companies (SGC) is a US group with three segments: branded promotional products and uniforms, healthcare apparel and nearshore contact centers. The company is under margin pressure, and in 2026 its sales guidance and tariff rules remain the points to watch.13

SWOT

Strengths

  • Three diversified segments and high customer retention reduce dependence on any single market.
  • Established brands and a flexible supply network are described by management as supporting competitiveness.
  • Management describes the balance sheet as healthy, which allows dividends and share repurchases when conditions permit.

Weaknesses

  • Gross margins declined in all three segments in 2025, which reduced net income.
  • The Contact Centers segment has lost sales as clients cut costs and new client acquisition has lagged attrition.
  • Reliance on materials and production in China and Haiti exposes the company to supply and trade-policy shocks.

Opportunities

  • If tariff refunds are completed, they could support margins in the second half of the year.
  • Demand for nearshore outsourcing could grow, and healthcare brands may keep gaining share.
  • Strategic acquisitions remain a growth path cited by management, provided integration goes well.

Threats

  • Tariff uncertainty and changes in trade rules could raise import costs.
  • Expiry or non-renewal of trade preferences for Haiti and Africa could raise production costs.
  • Strong competition and price-sensitive markets could limit pricing and margins.

Risks

  • Dependence on Chinese sourcinghigh

    Most raw materials come from China, and a disruption could seriously affect operations.1

  • Tariffs and trade policyhigh

    Tariff changes could raise costs and limit imports, and the current regime remains uncertain.12

  • Loss of major customersmedium

    Customers may cancel orders or reduce volumes, and changes at a major client could affect results.1

  • Intangible asset impairmentmedium

    The impairment of a tradename in the second quarter of 2026 shows asset values can decline, although it does not affect cash.23

  • Cybersecuritymedium

    Cyber-attacks and IT system failures could disrupt operations and damage reputation.1

Investment thesis

What would need to be true (bull case)

  • Diversification across three segments and high customer retention could support revenue stability if demand improves in the second half of the year.
  • Tariff refunds and lower cost pressure could lift gross margin above the levels seen in 2025.
  • Branded Products growth in the second quarter of 2026 shows the segment can offset weakness elsewhere.

What would break the thesis

  • Gross margins fell in 2025 across all segments, and net income declined sharply.
  • The tariff environment remains uncertain, and import costs could rise again if new tariffs apply broadly.
  • The Contact Centers segment is shrinking, and client losses could continue if the economic environment stays weak.

What to watch

  • Delivery of 2026 net sales guidance2026
  • Collection of tariff refunds and their effect on gross marginQ3 2026
  • Cost impact of the Section 301 tariffs effective July 2026next 10-Q
  • Performance of the Contact Centers segment after the Jamaica closure2026

Products, market & competition

AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.

The business

Superior Group of Companies, Inc. was organized in 1920 and operates in three reportable segments: Branded Products, Healthcare Apparel and Contact Centers. The Branded Products segment, through the BAMKO and HPI brands, produces customized merchandising solutions, promotional products and branded uniform programs for customers in retail, hospitality, food service and transport.1 Healthcare Apparel, through the Wink and Fashion Seal Healthcare brands, sells scrubs, lab coats and protective apparel to healthcare laundries and distributors, mainly in the United States.1 Contact Centers, under The Office Gurus name, provides outsourced services to North American clients and closed its Jamaica operations on June 15, 2025.1

As of December 31, 2025, the company had approximately 6,520 employees, most of them outside the United States, and the contact centers segment had the largest workforce.1 The company sources its main raw materials, cotton and polyester, largely from China, and contracts finished apparel in Bangladesh, China, Haiti, Madagascar, Vietnam and the United States, including its own facility in Haiti.1

The company is listed on NASDAQ under the symbol SGC and reports quarterly and annual results to the SEC.3

Segments

Healthcare Apparel

The Healthcare Apparel segment accounted for approximately 20% of net sales in 2025, down from 21% in 2024.1 In the second quarter of 2026 the company recorded a non-cash tradename impairment charge of 2.6 million dollars in this segment.23

Contact Centers

The Contact Centers segment accounted for approximately 16% of net sales in 2025, down from 17% in 2024, reflecting macroeconomic pressure and client downsizing.1

Market context

The company operates in fragmented markets: promotional products and uniforms are price-sensitive with demand cycles, while nearshore call-center services grow as firms seek lower costs without giving up quality.1 In the second quarter of 2026 management described soft market conditions but flagged growth opportunities in all three segments.3

For 2026 the company maintained net sales guidance of 572.0 million to 585.0 million dollars, compared with 566.2 million in 2025, with stronger results expected in the second half of the year due to seasonality.3

Trends

  • Tariffs and trade policyheadwind

    US tariffs increased in 2025, and in February 2026 the Supreme Court ruled that IEEPA tariffs were not authorized. Replacement tariffs on other legal bases followed, which could keep import costs elevated if clear rules are not set.12

  • Tariff refundstailwind

    The company recorded a tariff refund of 4.3 million dollars, of which 3.1 million was received in cash, and part was passed to customers. If refunds continue, they could support margins in 2026.2

  • Weak demand in contact centersheadwind

    Macroeconomic pressure has led to client downsizing and account attrition in the Contact Centers segment, and credit loss expense has risen.1

  • Nearshore outsourcingmixed

    Demand for nearshore operators offering comparable service at lower cost could grow, which could support the contact centers segment if new client acquisition recovers.1

Competitive position

In Branded Products the company competes with national and regional firms such as BDA, HALO Branded Solutions, Staples, Cimpress, HH Global and Lands' End, plus local firms in major cities. The company says its creative services, technology and global sourcing network keep it competitive.1

In Healthcare Apparel, competitors include Medline, Careismatic Brands, Barco Uniforms, FIGS, Encompass Medical and Standard Textile. In Contact Centers, competitors include TaskUs, Transparent BPO, Concentrix + Webhelp, Focus Services, Ubiquity, CCI and RDI, as well as clients' in-house operations.1

  • HALO Branded Solutions

    Competitor in promotional products and branding, named in the Branded Products segment.

  • Cimpress

    Competitor in customized branded products, named in the Branded Products segment.

  • Medline Industries

    Major competitor in hospital apparel, named in the Healthcare Apparel segment.

  • Concentrix

    Competitor in outsourced contact services, named in the Contact Centers segment.

News & filings

In the press

No news in our archive over the last 180 days.

SEC filings

Sources

  1. [1] Form 10-K, fiscal year ended 2025-12-31 · SEC / Superior Group of Companies, Inc. · 03 Mar 2026
  2. [2] Form 10-Q, quarter ended 2026-06-30 · SEC / Superior Group of Companies, Inc. · 04 Aug 2026
  3. [3] Form 8-K, results release (exhibit 99.1) · SEC / Superior Group of Companies, Inc. · 04 Aug 2026

Figures computed by olivLaw from SEC filings and closing prices; the qualitative analysis is AI-generated from cited sources. Not investment advice.